Physician profile
David Sing
NPI 1295276624
$109,432.85
in general payments reported to CMS, 2019-2025
17 companies · $5,717 in 2025
The $5,717 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $101K · 2024: $2,300 · 2025: $5,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $100K · Travel and Lodging: $5,880 · Food and Beverage: $3,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $100,000.00 |
| Travel and Lodging | $5,880.21 |
| Food and Beverage | $3,552.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $100,061.64 | 2023 | Xlif, Alif |
| Spineart USA INC | $2,395.72 | 2025 | |
| Globus Medical, INC. | $1,940.17 | 2023-2025 | Excelsiusgps Robotic Navigation System, Xlif, Modulus |
| Alphatec Spine, INC | $1,827.15 | 2024-2025 | Other - Miscellaneous, Invictus Mis |
| Arthrex, INC. | $1,268.34 | 2023-2025 | |
| Orthofix Medical, INC. | $431.28 | 2023-2024 | Mariner Deformity, Northstar, 7d Surgical System |
| Medtronic, INC. | $426.71 | 2023-2025 | Unid_pass, O-Arm, Stealthstation S8 Platform |
| Smith+Nephew, INC. | $384.61 | 2023 | Evos, Maverick, Evos Mini |
| Goode Surgical INC | $168.02 | 2025 | |
| Boston Scientific Corporation | $144.73 | 2024 | |
| Si-Bone, INC. | $143.52 | 2024 | |
| Stryker Corporation | $133.94 | 2023-2024 | Mako, Cascadia Interbody System, Ozark Cervical Plate System |
| Solventum Corporation | $25.35 | 2025 | Prevena |
| Ossdsign USA Incorporated | $24.97 | 2025 | Ossdsign Catalyst |
| Elevate Surgical Co | $20.23 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $19.21 | 2024 | Magnetos |
| Abbott Laboratories | $17.26 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.